Medable

Medable is a leading, universally recognized global platform for decentralized clinical trials (DCTs), fundamentally transforming how clinical research is conducted by placing an uncompromising focus on patient-centricity and digital innovation. The Medable platform provides a comprehensive, fully integrated suite of digital tools that safely replace traditional, site-heavy clinical trial processes with streamlined, remote-capable, and highly secure operations.

Their unified Software-as-a-Service (SaaS) platform integrates electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), remote patient monitoring via wearables, and highly secure telemedicine functionalities seamlessly. This robust digital infrastructure allows patients to participate in complex clinical trials primarily from the comfort of their own homes, effectively breaking down geographical barriers and massively improving trial diversity, patient recruitment speed, and long-term retention.

Medable has been successfully utilized in hundreds of critical trials across numerous therapeutic areas, consistently demonstrating the ability to drastically reduce overall study timelines and costs. The company places a paramount emphasis on the end-user patient experience, continually refining its digital interfaces based on direct patient feedback to ensure high engagement and compliance.

Recognized as one of the fastest-growing and most impactful health-tech companies globally, Medable partners extensively with major pharmaceutical companies and leading CROs to firmly usher in a new era of agile, highly inclusive, and efficient clinical drug development.